Minerva Neurosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $8.0M | $60.8M |
| FY2022 | — | $-20.0M | $36.1M |
| FY2023 | — | $-28.5M | $40.9M |
| FY2024 | — | $-25.7M | $21.4M |
| FY2025 | — | $-140.7M | $82.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $8.0M | $60.8M |
| FY2022 | — | $-20.0M | $36.1M |
| FY2023 | — | $-28.5M | $40.9M |
| FY2024 | — | $-25.7M | $21.4M |
| FY2025 | — | $-140.7M | $82.3M |